• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

物质滥用治疗机构中的公开性维度与绩效

Dimensions of publicness and performance in substance abuse treatment organizations.

作者信息

Heinrich Carolyn J, Fournier Elizabeth

机构信息

LaFollette School of Public Affairs, University of Wisconsin-Madison, USA.

出版信息

J Policy Anal Manage. 2004 Winter;23(1):49-70. doi: 10.1002/pam.10178.

DOI:10.1002/pam.10178
PMID:14976993
Abstract

Changes in funding, clientele, and treatment practices of public and privately owned substance abuse treatment programs, compelled in part by increased cost containment pressures, have prompted researchers' investigations of the implications of organizational form for treatment programs. These studies primarily probe associations between ownership status, patient characteristics, and services delivered and do not empirically link organizational form or structure to treatment outcomes. Data from the National Treatment Improvement Evaluation Study (NTIES) were used to study the relationship of ownership and other dimensions of publicness identified in the public management literature to patient outcomes, controlling for patient characteristics, treatment experiences, and other program characteristics. A few effects of organizational form and structure on substance abuse treatment outcomes are statistically significant (primarily improved social functioning), although the specific contributions of measures of ownership and publicness to explaining program-level variation are generally small.

摘要

公共和私人拥有的药物滥用治疗项目在资金、客户群体和治疗方法上的变化,部分是由于成本控制压力增加所迫,这促使研究人员对组织形式对治疗项目的影响进行调查。这些研究主要探究所有权状态、患者特征和提供的服务之间的关联,并未从实证角度将组织形式或结构与治疗结果联系起来。来自国家治疗改进评估研究(NTIES)的数据被用于研究所有权以及公共管理文献中所确定的其他公共性维度与患者结果之间的关系,同时控制患者特征、治疗经历和其他项目特征。尽管所有权和公共性衡量指标对解释项目层面差异的具体贡献通常较小,但组织形式和结构对药物滥用治疗结果的一些影响在统计上具有显著意义(主要是社会功能得到改善)。

相似文献

1
Dimensions of publicness and performance in substance abuse treatment organizations.物质滥用治疗机构中的公开性维度与绩效
J Policy Anal Manage. 2004 Winter;23(1):49-70. doi: 10.1002/pam.10178.
2
Organizational and client determinants of cost in outpatient substance abuse treatment.门诊药物滥用治疗中成本的组织和客户决定因素。
J Ment Health Policy Econ. 2007 Mar;10(1):3-13.
3
Ownership differences in the provision of outpatient substance abuse services.门诊药物滥用服务提供方面的所有权差异。
Adm Soc Work. 1994;18(3):59-91. doi: 10.1300/J147v18n03_03.
4
Treatment for substance abuse in Australia: a comparison of public and private programs.澳大利亚药物滥用治疗:公共项目与私人项目的比较
Int J Psychiatr Nurs Res. 2003 Sep;9(1):1025-38.
5
Integrating the delivery of privately and publicly funded substance abuse services.整合私人和公共资助的药物滥用服务的提供。
Behav Healthc Tomorrow. 1996 Apr;5(2):32-5, 60-1.
6
Managing the financial challenges of public-private collaboration.
Behav Healthc Tomorrow. 1995 Mar-Apr;4(2):31-4.
7
A guide to public constituencies.
Behav Healthc Tomorrow. 1995 Jul-Aug;4(4):59-61.
8
Dialogue. Should public sector mental health and substance abuse funding be merged?对话。公共部门用于心理健康和药物滥用的资金应该合并吗?
Behav Healthc Tomorrow. 1995 Nov-Dec;4(6):40-6.
9
New directions in alcohol and drug treatment under managed care.管理式医疗下酒精与药物治疗的新方向。
Am J Manag Care. 1999 Jun 25;5 Spec No:SP57-69.
10
The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national survey.备受赞誉的青少年药物滥用治疗项目的质量:一项深入的全国性调查结果
Arch Pediatr Adolesc Med. 2004 Sep;158(9):904-9. doi: 10.1001/archpedi.158.9.904.

引用本文的文献

1
Differential impact of hospital and community factors on breadth and depth of hospital population health partnerships.医院和社区因素对医院人群健康伙伴关系广度和深度的差异影响。
Health Serv Res. 2024 Feb;59 Suppl 1(Suppl 1):e14238. doi: 10.1111/1475-6773.14238. Epub 2023 Sep 20.
2
Association Between Interorganizational Collaboration in Opioid Response and Treatment Capacity for Opioid Use Disorder in Counties of Five States: A Cross-Sectional Study.五个州各县阿片类药物应对中的组织间合作与阿片类药物使用障碍治疗能力之间的关联:一项横断面研究
Subst Abuse. 2022 Jul 13;16:11782218221111949. doi: 10.1177/11782218221111949. eCollection 2022.
3
The publicness enigma: Can perceived publicness predict employees' formal and prosocial behavior across sectors?
公共性之谜:感知到的公共性能否预测不同行业员工的正式行为和亲社会行为?
PLoS One. 2022 Feb 10;17(2):e0262253. doi: 10.1371/journal.pone.0262253. eCollection 2022.
4
The Equity of Health Care Spending in South Korea: Testing the Impact of Publicness.韩国医疗支出公平性研究:公共性的影响检验
Int J Environ Res Public Health. 2020 Mar 9;17(5):1775. doi: 10.3390/ijerph17051775.
5
Access to Recovery and Recidivism Among Former Prison Inmates.曾经入狱者的康复途径与再犯罪情况
Int J Offender Ther Comp Criminol. 2017 Jun;61(8):874-893. doi: 10.1177/0306624X15606688. Epub 2015 Sep 17.
6
Substance abuse and batterer programmes in California, USA: factors associated with treatment outcomes.美国加利福尼亚州的药物滥用与施暴者项目:与治疗结果相关的因素
Health Soc Care Community. 2015 Nov;23(6):642-53. doi: 10.1111/hsc.12178. Epub 2014 Dec 3.
7
Treatment outcomes for prescription drug misusers: the negative effect of geographic discordance.处方药滥用者的治疗结果:地理不匹配的负面影响。
J Subst Abuse Treat. 2015 Jan;48(1):77-84. doi: 10.1016/j.jsat.2014.08.002. Epub 2014 Aug 12.
8
The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.在公共资助的物质使用障碍治疗项目中采用药物治疗的转变:组织结构、文化和资源。
J Stud Alcohol Drugs. 2014 May;75(3):476-85. doi: 10.15288/jsad.2014.75.476.
9
Adoption and diffusion of evidence-based addiction medications in substance abuse treatment.在物质滥用治疗中采用和推广基于证据的成瘾药物。
Health Serv Res. 2014 Feb;49(1):127-52. doi: 10.1111/1475-6773.12093. Epub 2013 Jul 16.
10
Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.美国公共和私人资助的治疗项目在获得治疗物质使用障碍的医生和药物方面的差异。
J Stud Alcohol Drugs. 2013 Mar;74(2):258-65. doi: 10.15288/jsad.2013.74.258.